top of page
Image by airfocus

We Put Our Science to Work for Patients

We’re transforming discovery into medicine, pioneering new possibilities in Immunology, Oncology, Neuroscience, Rare Disease, and beyond.

Innovation, inspired by real people

See how real lives — not just conditions — shape our science.

Face Paint

Areas of Focus: At a Glance

Finding innovative solutions for unmet medical needs is at the heart of what we do. Our ideas and research help save lives.

Image by National Cancer Institute

Oncology

Since 2023, Genventis have collaborated with patient on a variety of blood and marrow disorders such as lymphoma, leukemia, multiple myeloma, aplastic anemia and sickle cell anemia. We possess specialized expertise in hematopoietic stem cell transplantation (HSCT), cellular therapy and gene therapy.

Image by National Cancer Institute

Cardiovascular Disease

Clients leverage a broad range of expertise in neurological and psychiatric disorders possessed by our neuroscience therapeutic research unit. We have significant experience in traumatic brain injury, stroke, epilepsy, autism, depression, schizophrenia and substance use disorders.

Lasers are used to position a patient mo

Neuroscience

Clients leverage a broad range of expertise in neurological and psychiatric disorders possessed by our neuroscience therapeutic research unit. We have significant experience in traumatic brain injury, stroke, epilepsy, autism, depression, schizophrenia and substance use disorders.

Image by Ed Us

Vaccines and Infectious Diseases

As a biotech company,  Geventis has worked on nearly every epidemic and pandemic since our founding in 2023, including HIV-AIDs, Zika Virus, Ebola, SARS, MERS, H1N1, and COVID-19.

woman's face_edited_edited_edited.jpg

Ophthalmology

Patient seek Genventis’s  Ophthalmology clinical research services for a variety of disorders including age-related macular degeneration, glaucoma, diabetic retinopathy, and rare diseases.

Image by National Cancer Institute

Rare Disease

Clinical research on rare diseases has proliferated since the passage of the Orphan Drug Act in 2017. BioFicher has helped clients conduct rare disease research across several therapeutic areas including infectious diseases, ophthalmology, oncology, autoimmune, neurology, and hematology.

Participate in a Trial

To learn more about how Bioficher can help you with biostatistical analysis, please contact us.

bottom of page